ArticleJournal of gastric cancer2017
Plexiform Angiomyxoid Myofibroblastic Tumor of the Stomach: a Rare Case.
Article in Journal of gastric cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.
- Pooled it
- Endoscopic submucosal excavation for gastric plexiform fibromyxoma: A case report and systematic review of literature.Frontiers in oncology · 2023Article
- Plexiform angiomyxoid myofibroblastic tumor treated by endoscopic submucosal dissection: A case report and review of the literature.World journal of gastroenterology · 2021Review
- Plexiform fibromyxoma: a clinicopathological and immunohistochemical analysis of two cases with a literature review.The Journal of international medical research · 2021Review
- Clinicopathological features and differential diagnosis of gastrofibromatosis-like undifferentiated carcinoma.The Journal of international medical research · 2020Article
- Gastric aggressive fibromatosis: report of a case and review of the literature.International journal of clinical and experimental pathology · 2019Article
- An Update on Clinicopathological and Molecular Features of Plexiform Fibromyxoma.Canadian journal of gastroenterology & hepatology · 2019Review
- Plexiform fibromyxoma of the small bowel: A case report.World journal of clinical cases · 2018Article
- Plexiform fibromyxoma of the stomach: a clinicopathological study of 10 cases.International journal of clinical and experimental pathology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plexiform angiomyxoid myofibroblastic tumor (PAMT) of the stomach is a very rare mesenchymal tumor of the gastrointestinal tract. We report a case of asymptomatic gastric PAMT that was pathologically confirmed after surgical resection. The tumor had a multinodular plexiform growth pattern, bland-looking spindle cells, and an Alcian blue-positive myxoid stromal matrix rich in small blood vessels. Immunohistochemistry analysis revealed that the tumor cells of the PAMT were positive for smooth muscle actin (SMA) and negative for c-kit, CD34, S-100 protein, epithelial membrane antigen (EMA), and desmin. PAMT should be differentiated from other submucosal tumors of the stomach by immunohistochemical findings. Considering the benign features of this tumor, observation without resection may be an option for the treatment of PAMT if the tumor is asymptomatic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.